Treatment with elafibranor to normalize alkaline phosphatase in patients with primary biliary cholangitis and incomplete response to ursodeoxycholic acid: Results from the phase III randomized controlled ELSPIRE trial

Kris V. Kowdley, Eric Lawitz, Christopher L. Bowlus, Kuldeep Cheent, Matthieu Guivarch, Vaclav Hejda, Jeong Heo, Byoung K. Jang, Wonseok Kang, Carmen Landaverde, Anna S. Lok, Ashis Mukhopadhya, Antonio Olveira, Bhaktasharan Patel, Fabian Rodas Ochoa, Sergio Rodríguez-Tajes, Jan Sperl, Frank E. Uschner, Ziad Younes, Gillian Bubb, Valeria Cranham, George Harb, Claire Raskino, Philip J. F. Troke, Benjamin Miller, Ana Lleo, Unknown

Open source

DOI: 10.1097/hep.0000000000001906
Published: 2026-11-05
Container: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/hep.0000000000001906,
  title = {Treatment with elafibranor to normalize alkaline phosphatase in patients with primary biliary cholangitis and incomplete response to ursodeoxycholic acid: Results from the phase III randomized controlled ELSPIRE trial},
  author = {Kris V. Kowdley and Eric Lawitz and Christopher L. Bowlus and Kuldeep Cheent and Matthieu Guivarch and Vaclav Hejda and Jeong Heo and Byoung K. Jang and Wonseok Kang and Carmen Landaverde and Anna S. Lok and Ashis Mukhopadhya and Antonio Olveira and Bhaktasharan Patel and Fabian Rodas Ochoa and Sergio Rodríguez-Tajes and Jan Sperl and Frank E. Uschner and Ziad Younes and Gillian Bubb and Valeria Cranham and George Harb and Claire Raskino and Philip J. F. Troke and Benjamin Miller and Ana Lleo and Unknown},
  year = {2026},
  journal = {Hepatology},
  doi = {10.1097/hep.0000000000001906},
  url = {https://doi.org/10.1097/hep.0000000000001906}
}

RIS

TY  - JOUR
TI  - Treatment with elafibranor to normalize alkaline phosphatase in patients with primary biliary cholangitis and incomplete response to ursodeoxycholic acid: Results from the phase III randomized controlled ELSPIRE trial
AU  - Kris V. Kowdley
AU  - Eric Lawitz
AU  - Christopher L. Bowlus
AU  - Kuldeep Cheent
AU  - Matthieu Guivarch
AU  - Vaclav Hejda
AU  - Jeong Heo
AU  - Byoung K. Jang
AU  - Wonseok Kang
AU  - Carmen Landaverde
AU  - Anna S. Lok
AU  - Ashis Mukhopadhya
AU  - Antonio Olveira
AU  - Bhaktasharan Patel
AU  - Fabian Rodas Ochoa
AU  - Sergio Rodríguez-Tajes
AU  - Jan Sperl
AU  - Frank E. Uschner
AU  - Ziad Younes
AU  - Gillian Bubb
AU  - Valeria Cranham
AU  - George Harb
AU  - Claire Raskino
AU  - Philip J. F. Troke
AU  - Benjamin Miller
AU  - Ana Lleo
AU  - Unknown
PY  - 2026
JO  - Hepatology
DO  - 10.1097/hep.0000000000001906
UR  - https://doi.org/10.1097/hep.0000000000001906
ER  -

APA

Kowdley, K. V., Lawitz, E., Bowlus, C. L., Cheent, K., Guivarch, M., Hejda, V., Heo, J., Jang, B. K., Kang, W., Landaverde, C., Lok, A. S., Mukhopadhya, A., Olveira, A., Patel, B., Ochoa, F. R., Rodríguez-Tajes, S., Sperl, J., Uschner, F. E., Younes, Z., Bubb, G., Cranham, V., Harb, G., Raskino, C., Troke, P. J. F., Miller, B., Lleo, A., & Unknown (2026). Treatment with elafibranor to normalize alkaline phosphatase in patients with primary biliary cholangitis and incomplete response to ursodeoxycholic acid: Results from the phase III randomized controlled ELSPIRE trial. Hepatology. https://doi.org/10.1097/hep.0000000000001906

Source records

crossref · retrieved 2026-11-07T14:01:00.592Z